BackMiNK Therapeutics Overview

MiNK Therapeutics Total Liabilities

MiNK Therapeutics's total liabilities is $0.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$0.00

Peer average

Loading

MiNK Therapeutics Total Liabilities History

Loading

MiNK Therapeutics vs. peers: Total Liabilities Comparison

Loading

MiNK Therapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

MiNK Therapeutics (INKT) FAQ

The latest total liabilities for INKT is $0 as of March 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside MiNK Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, INKT's total liabilities moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in MiNK Therapeutics's operating scale or balance-sheet position.

A total liabilities figure of $0 for INKT is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting INKT's total liabilities ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack MiNK Therapeutics's total liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.